SkinnyRx Review
Budget-friendly compounded GLP-1 with multiple formulation options
Last updated · Read our methodology
- Injectable and tablet options for both semaglutide and tirzepatide
- Competitive starting prices, confirmed on SkinnyRx's own site
- Simple cash-pay model, no insurance complexity
- Independently verified Trustpilot record: 4.8/5 across 5,310 reviews
- The offending marketing language cited in the FDA's February 2026 letter no longer appears on the live site
- FDA warning letter (February 2026) for marketing language implying compounded products were equivalent to FDA-approved medications — see below
- Advertised "90-Day Money-Back Guarantee" only pays out for zero measurable weight loss, not a percentage shortfall
- No ongoing physician or coach support beyond initial prescription
- No large-scale published clinical outcome data of its own; the "up to 14.9%" figure is self-reported, not a trial result
- Compounded medications are not FDA-approved and may vary in potency
- Not BBB accredited
| Scoring Criterion | Score / 10 |
|---|---|
| Clinical Effectiveness | 6.5 |
| Cost & Transparency | 7.0 |
| Program Comprehensiveness | 6.0 |
| Accessibility & Convenience | 7.5 |
| Customer Satisfaction | 7.5 |
What They Offer
SkinnyRx is a telehealth platform offering compounded GLP-1 medication access at a cash-pay price, prescribed by licensed U.S. providers who review each patient's intake before issuing a prescription. Compounded semaglutide and tirzepatide are each available as an injectable or an oral tablet. SkinnyRx has also added two FDA-approved options billed through a SkinnyRx membership — the Wegovy Pill and Foundayo (orforglipron) — though as of this review neither had a public price and Wegovy Pill was marked unavailable on the site. We could not confirm a sublingual (dissolvable) formulation is currently for sale; it is not listed among SkinnyRx's current product tiles, so we have removed it from the pricing table below rather than repeat an unconfirmed offering.
Pricing & Plans
Prices below were read directly off skinnyrx.com on August 12, 2026. They are listed as "from" / starting prices — the dose you're prescribed can raise the amount you're actually charged at checkout, and SkinnyRx does not publish a dose-by-dose price ladder.
| Plan | Price | Includes |
|---|---|---|
| Semaglutide (Injectable) | From $199/mo | 4-week supply; consultation included |
| Semaglutide (Tablet) | From $249/mo | 4-week supply; consultation included |
| Tirzepatide (Injectable) | From $299/mo | 4-week supply; consultation included |
| Tirzepatide (Tablet) | From $299/mo | 4-week supply; consultation included |
| Wegovy Pill / Foundayo (FDA-approved, via membership) | Not published | Wegovy Pill listed as unavailable at time of check; Foundayo price not shown publicly |
We could not independently confirm whether a separate consultation, membership, or shipping fee applies beyond the listed medication price — SkinnyRx's own terms do not state one exists, but we would rather flag that as unconfirmed than assert "no fees."
What's Included
- Licensed provider telehealth consultation
- Medication prescription and delivery coordination
- Choice of injectable or tablet, for semaglutide or tirzepatide
- Shipping from a compounding pharmacy
- In-app weight and dose logging (also the mechanism for the 90-Day Guarantee — see below)
Eligibility
BMI 30+, or BMI 27+ with a weight-related health condition. Must be 18+. Available in most U.S. states (some restrictions may apply). Not eligible if history of medullary thyroid cancer or MEN2 syndrome.
Is SkinnyRx Legit? The FDA Warning Letter Explained
SkinnyRx is a real, operating telehealth company — Lean Rx, Inc., based in Sacramento, CA — using licensed U.S. providers. It is not a scam and people do receive medication. There is regulatory history, though, that a page answering "is SkinnyRx legit" cannot leave out.
On February 20, 2026, the FDA's Center for Drug Evaluation and Research issued a warning letter to Lean Rx, Inc. dba SkinnyRx (MARCS-CMS 717989) after reviewing skinnyrx.com in December 2025. The letter cited two problems:
- Labeling implied SkinnyRx compounds the drug itself. The FDA said the compounded semaglutide and tirzepatide pictured on the site displayed "SkinnyRx" on the label, "suggesting SkinnyRx is the compounder of those drugs when in fact it is not" — making the products misbranded under FDCA sections 502(a) and 502(bb).
- Marketing implied FDA-approved equivalence. The FDA quoted three specific claims from the site: "from the same family as GLP-1 treatments like Mounjaro® and Zepbound®," "Get access to the same active ingredient as name-brand GLP-1 medications," and "It contains the same active ingredient as FDA-approved medications." Because compounded drugs are not FDA-approved, the agency said these claims falsely implied the products had been evaluated for safety and effectiveness when they had not.
What this letter is not: it is not a finding of contamination, a recall, a safety alert, or evidence of patient harm. It is an enforcement action about advertising and labeling language, and SkinnyRx was given 15 working days to describe corrective steps. Dozens of compounded-GLP-1 telehealth companies have received similar letters over the same underlying issue.
Has the language changed? Yes, as best we can tell. We checked skinnyrx.com's homepage, product pages, and terms of service directly on August 12, 2026, and none of the three quoted phrases — nor "same family," "same active ingredient," "Mounjaro," or "Zepbound" — currently appear. The site now carries an explicit disclaimer: "Compounded drugs are not FDA-approved or evaluated for safety, effectiveness, or quality by the FDA," alongside a note that "product images are illustrative and the actual product received may differ in appearance." We could not verify whether the physical product label itself (the specific labeling issue the FDA cited) has been changed, since that isn't visible from the website. You can read the letter yourself at FDA.gov.
Other legitimacy signals we verified directly: SkinnyRx is not BBB accredited (confirmed at bbb.org). On Trustpilot, SkinnyRx carries a 4.8 out of 5 TrustScore from 5,310 reviews (confirmed directly at trustpilot.com on August 18, 2026) — a strongly positive independent record that sits alongside, not in place of, the FDA disclosure above.
The 90-Day Money-Back Guarantee: What It Actually Requires
SkinnyRx advertises a "90-Day Money-Back Guarantee." Its terms of service (Section 19) spell out a narrower program than the marketing name suggests:
| Requirement | What the terms actually say |
|---|---|
| Enrollment | 90 consecutive days of continuously paid SkinnyRx membership |
| Logging | Body weight logged in the SkinnyRx app at least once per calendar week, every week, for the full 90 days — plus each medication dose logged weekly |
| The qualifying condition | Your logged weight at the end of the 90 days must be equal to or greater than your logged weight at the start — not a percentage shortfall, and not "less than expected" progress. Any measurable weight loss disqualifies the claim. |
| Verification | Eligibility is based solely on self-reported log data; SkinnyRx may audit logs for "completeness, consistency, and plausibility" and can deny a claim it judges unreliable, or request written provider attestation |
| Claim window | Must be submitted within 14 calendar days after the 90-day period ends; late claims are not honored |
| What is refunded | For compounded programs, the full amount paid to SkinnyRx during the period. For the branded/membership pathway (Wegovy Pill, Foundayo), only the SkinnyRx membership fee — not any separate third-party pharmacy charge |
| Limits | Once per customer account, non-transferable, cannot combine with other offers unless SkinnyRx states otherwise in writing |
SkinnyRx's own terms are explicit that this is "a commercial satisfaction program only" and "does not constitute a guarantee of any medical outcome or therapeutic result." Read plainly: this pays out if you did not lose any weight at all after three months of active use, not if you fell short of a target. It does not promise a specific percentage of weight loss, and it does not prorate for partial progress.
Clinical Effectiveness & Results
SkinnyRx's own site advertises "lose up to 14.9% of your body weight in 4 easy steps," with a footnote stating this figure is "based on self-reported data from 1,981 of our members while on GLP-1 injections, while combined with diet and exercise." That is company-collected, self-reported customer data — not a clinical trial, not independently verified, and a ceiling ("up to"), not a typical or average result. It applies to injectable GLP-1 use specifically, alongside diet and exercise changes, not to the tablet formulations or to medication alone. We are not aware of any published clinical trial of SkinnyRx's own compounded product; figures from FDA trials of approved drugs like Ozempic, Wegovy, or Zepbound (the STEP and SURMOUNT trial programs) do not apply to a compounded product with a different manufacturer, formulation, and regulatory status, so we have not cited them here.
Because compounded semaglutide and tirzepatide are not FDA-approved, they do not undergo the FDA's premarket review for safety, effectiveness, and quality, and the agency notes that some compounded products may even use different salt forms of the active ingredient (FDA: Concerns With Unapproved GLP-1 Drugs Used for Weight Loss).
Customer Experience
Independently, SkinnyRx carries a 4.8 out of 5 TrustScore across 5,310 Trustpilot reviews, confirmed directly at Trustpilot on August 18, 2026 — a genuinely strong record for this category. Set against that: the program offers minimal ongoing coaching or check-ins beyond the initial prescription, so it suits self-directed patients more than those wanting behavioral support, and the 90-Day Guarantee's strict logging and zero-loss requirement means most customers who do lose weight (the outcome they're presumably paying for) will not be eligible for it.
Frequently Asked Questions
How much does SkinnyRx cost?
As of a direct check of skinnyrx.com on August 12, 2026, SkinnyRx lists compounded injectable semaglutide from $199/mo, compounded semaglutide tablets from $249/mo, and compounded injectable or tablet tirzepatide from $299/mo. These are "from" starting prices, not flat rates, and the dose you are prescribed can push the checkout price higher. We could not confirm a sublingual (dissolvable) product currently for sale — see the pricing section below.
What medications does SkinnyRx offer?
Compounded semaglutide and tirzepatide, each available as an injectable or a tablet. SkinnyRx also now lists FDA-approved Wegovy Pill and Foundayo (orforglipron) as membership options, though neither had a public price at the time we checked; Wegovy Pill was marked "Unavailable" on the site.
Is SkinnyRx legitimate?
SkinnyRx is a real, operating telehealth company (Lean Rx, Inc., Sacramento, CA) that prescribes through licensed U.S. providers, and it is not a scam. It is not without regulatory history, though: the FDA issued a warning letter on February 20, 2026 over marketing language that implied its compounded drugs were the same as, or equivalent to, FDA-approved medications. That letter concerned advertising claims, not drug safety, contamination, or patient harm — see the full explanation below.
Does SkinnyRx have a money-back guarantee?
Yes, but it is narrower than "money-back guarantee" implies. SkinnyRx's terms describe a 90-Day Money-Back Guarantee that only pays out if your logged weight at the end of 90 days is equal to or greater than your logged weight at the start — meaning any measurable weight loss, even a small amount, disqualifies the claim. It also requires weekly weight and dose logs in the SkinnyRx app for the full 90 days and a claim filed within 14 days of the period ending.
Does SkinnyRx accept insurance?
No. SkinnyRx is cash-pay only and does not bill traditional insurance.
Our Verdict
SkinnyRx is a reasonable pick for cost-sensitive, self-directed patients comfortable with compounded medication — starting prices from $199–$299/mo are competitive, and the independently verified 4.8/5 Trustpilot record across 5,310 reviews is a genuinely strong signal. Two things keep the score at 7.0 rather than higher. First, the FDA issued the company a warning letter in February 2026 for marketing language that implied its compounded products were equivalent to FDA-approved medication — that language appears to be gone from the live site now, but it belongs in front of anyone deciding. Second, the advertised "90-Day Money-Back Guarantee" is not the safety net it sounds like: it only pays out if you show zero measurable weight loss over 90 days of strict weekly self-logging, so it should not be a reason to choose SkinnyRx over a competitor.
Choose it if you want low starting prices, are comfortable with compounded medication, and don't need ongoing coaching. Look elsewhere if you're relying on the money-back guarantee, want FDA-approved brand-name medication with a track record on this page, or want behavioral support built into the program.
Get Started →Disclosures
Affiliate Disclosure: GLP1Authority.com may earn commissions from referrals or affiliate partnerships. This review reflects our independent assessment and does not influence our ratings.
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. Please consult with a healthcare provider before starting any GLP-1 weight loss program.
Stay Informed
Get the GLP-1 Insider Brief
Exclusive provider discounts, healthy living guides for your GLP-1 journey, and the latest breakthroughs in peptide science — delivered free.
No spam. Unsubscribe any time.